SFM
VIVO

Systematic Financial Management’s Meridian Bioscience Inc VIVO Stock Holding History

Systematic Financial Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-643,487
Closed -$21.4M – 321
2022
Q4 		$21.4M Sell
643,487
-105,216
-14% -$3.39M 0.7% 57
2022
Q3 		$23.6M Buy
748,703
+8,505
+1% +$275K 0.86% 30
2022
Q2 		$22.5M Sell
740,198
-20,048
-3% -$542K 0.78% 43
2022
Q1 		$19.7M Sell
760,246
-27,249
-3% -$648K 0.62% 80
2021
Q4 		$16.1M Sell
787,495
-4,593
-0.6% -$88.1K 0.48% 98
2021
Q3 		$15.2M Buy
792,088
+2,261
+0.3% +$45.1K 0.47% 97
2021
Q2 		$17.5M Buy
789,827
+68,651
+10% +$1.46M 0.53% 90
2021
Q1 		$18.9M Sell
721,176
-16,868
-2% -$401K 0.69% 61
2020
Q4 		$13.8M Buy
738,044
+4,168
+0.6% +$77.8K 0.61% 76
2020
Q3 		$12.5M Sell
733,876
-141,297
-16% -$2.75M 0.68% 67
2020
Q2 		$20.4M Sell
875,173
-366,012
-29% -$5.3M 1.06% 16
2020
Q1 		$10.4M Sell
1,241,185
-85,199
-6% -$717K 0.64% 63
2019
Q4 		$13M Buy
1,326,384
+77,808
+6% +$730K 0.51% 93
2019
Q3 		$11.8M Buy
1,248,576
+55,388
+5% +$584K 0.53% 90
2019
Q2 		$14.2M Buy
1,193,188
+44,769
+4% +$539K 0.55% 73
2019
Q1 		$20.2M Sell
1,148,419
-2,478
-0.2% -$41.2K 0.69% 26
2018
Q4 		$20M Buy
1,150,897
+10,473
+0.9% +$179K 0.61% 27
2018
Q3 		$17M Buy
1,140,424
+8,709
+0.8% +$135K 0.41% 77
2018
Q2 		$18M Buy
1,131,715
+114,687
+11% +$1.71M 0.44% 64
2018
Q1 		$14.4M Buy
1,017,028
+128,953
+15% +$1.91M 0.32% 112
2017
Q4 		$12.4M Buy
888,075
+790,508
+810% +$11.6M 0.25% 140
2017
Q3 		$1.4M Sell
97,567
-16,155
-14% -$231K 0.03% 473
2017
Q2 		$1.79M Sell
113,722
-25,410
-18% -$366K 0.03% 382
2017
Q1 		$1.92M Buy
139,132
+38,265
+38% +$535K 0.03% 350
2016
Q4 		$1.78M Buy
100,867
+13,755
+16% +$242K 0.03% 427
2016
Q3 		$1.68M Sell
87,112
-9,265
-10% -$181K 0.02% 457
2016
Q2 		$1.88M Buy
96,377
+14,595
+18% +$286K 0.03% 344
2016
Q1 		$1.69M Sell
81,782
-7,270
-8% -$143K 0.02% 420
2015
Q4 		$1.83M Sell
89,052
-31,905
-26% -$612K 0.02% 355
2015
Q3 		$2.07M Sell
120,957
-18,425
-13% -$337K 0.02% 447
2015
Q2 		$2.6M Buy
139,382
+13,977
+11% +$259K 0.02% 386
2015
Q1 		$2.39M Sell
125,405
-7,420
-6% -$137K 0.02% 498
2014
Q4 		$2.19M Buy
+132,825
New +$2.28M 0.02% 535
2014
Q2 		– Sell
-86,155
Closed -$1.88M – 746
2014
Q1 		$1.88M Buy
86,155
+10,620
+14% +$243K 0.01% 518
2013
Q4 		$2M Buy
75,535
+12,625
+20% +$310K 0.01% 423
2013
Q3 		$1.49M Sell
62,910
-7,200
-10% -$168K 0.01% 493
2013
Q2 		$1.51M Buy
+70,110
New +$1.51M 0.01% 419

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Systematic Financial Management's VIVO Position: Q1 2023 in Review

Systematic Financial Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 643,487 shares — an estimated $21.4M sold.

Systematic Financial Management first reported a position in VIVO in Q2 2013 and held it in 37 quarters. The position peaked at $23.6M in Q3 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Systematic Financial Management reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Systematic Financial Management sold 643,487 Meridian Bioscience Inc shares in Q1 2023, an estimated $21.4M.
  • Systematic Financial Management first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 37 quarters.
  • Systematic Financial Management's Meridian Bioscience Inc position peaked at $23.6M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Systematic Financial Management's 13F filing for Q1 2023, filed 12 May 2023.